Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Glucagon analogue linked to a human immunoglobulin Fc fragment

EU orphan designation number: EU/3/18/2022   
Active ingredient: Glucagon analogue linked to a human immunoglobulin Fc fragment
Indication: Treatment of congenital hyperinsulinism
Sponsor: JVM Europe B.V.
Niels Bohrweg 6, Lelystad, Flevoland, 8218 MD, Nederland

  

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
29/05/2018 Orphan designation EMA/OD/257/17 (2018)3389 of 25/05/2018
12/04/2019 Transfer of orphan designation EMA/OD/0000005277 2920 of 10/04/2019